Zusammenfassung
Der Name des Tumors geht auf den Wiener Arzt Moritz Kaposi zurück. Dieser beschrieb 1872 als erster multilokulär auftretende rötlich-livide sarkomatöse Hauttumoren, die er an 5 Patienten beobachtet hatte [18]. Der damals seltene und in der Ärzteschaft kaum bekannte Tumor wurde wenig später nach seinem Erstbeschreiber als Kaposi-Sarkom benannt. Epidemiologische und klinische Beobachtungen führten in der darauffolgenden Zeit zur Einteilung dieses Tumors in verschiedene Typen, die sich sowohl klinisch und auch geographisch gut voneinander abgrenzen lassen (Tabelle 5.1).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Albini A, Barillari G, Benelli R, Gallo RC, Ensoli B (1995) Angiogenic properties of human immunodeficiency virus typ 1 Tat protein. Proc Natl Acad Sci USA 92: 4838–4842
Beral V, Bull D, Darby S, Weller I, Carne C, Beecham M, Jaffe H (1992) Risk of Kaposi’s sarcoma and sexual practices associated with feacal contact in homosexual or bisexual men with AIDS. Lancet 339: 632–635
Beral V, Peterman TA, Berkelman AL, Jaffe HW (1990) Kaposi’s sarcoma among persons with AIDS: A sexually transmitted infection? Lancet 335: 123–128
Berkelmann RL, Heyward WL, Stehr-Green JK, Curran JW (1989) Epidemiology of human immunodeficiency virus infection and aquired immunodeficiency syndrome. Am J Med 86: 761–769
Boldogh I, Beth E, Huang ES, Kyalwazi SK, Giraldo G (1981) Kaposi’s sarcoma: Detection of CMV-DNA, CMV-RNA and CMNA in tumor biopsies. Int J Cancer 29: 469–474
Boshoff C, Schulz TF, Kennedy M et al. (1995) Kaposi’s sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med 1: 1274–1278
Boshoff C, Talbot S, Kennedy M, O’Leary J, Schulz Th, Chang Y (1996) HHV-8 and skin cancers in immunosuppressed patients. Lancet 347: 338–339
Cesarman E, Chang Y, Moore PS, Jonathan WS, Knowles DM (1995) Kaposi’ sarcoma associated herpesvirus-like DNA in AIDS-related body-cavity-based lymphomas. N Engl J Med 332: 1186–1191
Chang Y, Cesarmen E, Pessin S, Lee F, Culpepper J, Knowles DM, Moore PS (1994) Identification of herpes-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 266: 1865–1869
Drew WL, Conant MA, Miner RC (1982) Cytomegalovirus and Kaposi’s sarcoma in young homosexual men. Lancet 2: 125–127
Ensoli B, Barillari G, Gallo RC (1991) Pathogenesis of AIDS-associated Kaposi’s sarcoma. Haematol/Oncol Clin North Am 5: 281–295
Ensoli B, Barillari G, Salahuddin SZ, Gallo RC, Wong-Staal F (1990) Tat protein of HIV-i stimulates growth of cells derived from Kaposi’s sarcoma lesions of AIDS patients. Nature 345: 84–86
Ensoli B, Gendelmann R, Markham PH etal. (1994) Syn-ergy between basic fibroblast growth factor and HIV-i Tat protein in induction of Kaposi’s sarcoma. Nature 371: 674–680
Ensoli B, Markham P, Kao V (1994) Block of AIDS-Kaposi’s sarcoma (KS) cell growth, angiogenesis and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. J Clin Invest 94: 1736–1746
Giraldo G, Beth E, Huang ES (1980) Kaposi’s sarcoma and its relationsship to cytomegalovirus (CMV). CMV-DNA and CMV early antigens in Caposi’s sarcoma. Int J Cancer 26: 23–29
Huang YQ, Li IJ, Kaplan MH et al. (1995) Human herpes-virus-like nucleic acid in various forms of Kaposi’s sarcoma. Lancet 345: 759–761
Jahan N (1989) Analysis of human Kaposi’s sarcoma biopsies and cloned cell lines for cytomegalovirus, HIV-i and other selected DNA-virus sequences. AIDS Res Hum Retro 5: 225
Kaposi M (1872) Idiopathisches multiples Pigmentsarkom der Haut. Arch Derm Syph 4: 742–749
Moore PS, Chang Y (1995) Detection of herpesvirus-like DNA sequences in Kaposi’s sarcoma in patients with and thouse without HIV-infection. N Engl J Med 332: 1181–1185
Miles SA, Rezai AR, Salazar-Gonzalez JF (1990) AIDS- Kaposi’s sarcoma-derived cells produce and respond to interleukin-6. Proc Natl Acad Sci 87: 4068–4072
Nair BC, De Vico AL, Nakamura S (1992) Identification of major growth factor for AIDS Kaposi’s sarcoma cells as oncostatin M. Science 225: 1430–1432
Oettle AG (1962) Geographical and racial differences in the frequency of Kaposi’s sarcoma as evidence of environmental or genetic causes. Acta Unio Int Contra Cancrum 18: 330–363
Penn I (1979) Kaposi’s sarcoma in organ transplant recipients. Report of 20 cases. Transplantation 27: 8–11
Rady PL, Yen A, Rollefson JL, Orengo I, Bruce S, Hughes TK, Tyring SK (1995) Herpesvirus-like DNA-sequences in non-Kaposi’s sarcoma skin lesions of transplant patients. Lancet 345: 1339–1340
Safai B, Meik V, Giraldo G (1980) Association of Kaposi’s sarcoma with second primery malignancies: possible etiopathogenic implications. Cancer 45: 1472–1479
Voßmann D, Thies W, Bauer R, Orfanos CE (1983) Disseminiertes Kaposi-Sarkom der Haut bei einem jungen Homosexuellen mit Drogenabusus. Hautarzt 34: 339–345
Wahmann A, Melnick SL, Rhame FS (1991) The epidemiology of classic, African and immunocompromised Kaposi’s sarcoma. Epidemiol Rev 13: 178–199
Whitby D, Howard MR, Tenant-Flowers M et al. (1995) Detection of Kaposi’s sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi’s sarcoma. Lancet 346: 799–802
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Wölfer, LU. (1997). Epidemiologie und Pathogenese des HIV-assoziierten Kaposi-Sarkoms. In: Garbe, C., Dummer, R., Kaufmann, R., Tilgen, W. (eds) Dermatologische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60622-9_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-60622-9_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64480-1
Online ISBN: 978-3-642-60622-9
eBook Packages: Springer Book Archive